HIV/AIDS

/0 Comments/in /by

FDA approves Juluca (dolutegravir and rilpivirine) for the maintenance treatment of certain patients with HIV-1 infection.

Read more

Multiple Sclerosis

/0 Comments/in /by

Mavenclad (cladribine) has become the multiple sclerosis therapy of choice for 1 in 5 neurologists in Germany and the UK. Meanwhile, many European neurologists wait for Ocrevus (ocrelizumab).

Read more

Lung cancer

/0 Comments/in /by

A phase 3 study on lung cancer showed that Imfinzi (durvalumab) as a consolidation therapy reduced the risk of the disease progressing by 48 percent.

Read more

Biosimilars

/0 Comments/in /by

The FDA has approved the first biosimilar for the treatment of certain breast and stomach cancers.

Read more

Lung cancer

/0 Comments/in /by

Researchers are suggesting that metastatic tumours in the lung can be successfully eradicated using cryotherapy – literally turning the masses into ice balls that are then resorbed by the body.

Read more

Lung cancer

/0 Comments/in /by

Eight important updates in lung cancer.

Read more

Melanoma

/0 Comments/in /by

Specific strains of intestinal bacteria can improve the response rate to immunotherapy for patients being treated for advanced melanoma.

Read more

Esophageal cancer

/0 Comments/in /by

Pembrolizumab showed positive results in heavily pretreated, PD-L1–positive advanced esophageal carcinoma.

Read more

HIV/AIDS

/0 Comments/in /by

The FDA has approved a new HIV treatment for patients with limited treatment options.

Read more

Prostate cancer

/0 Comments/in /by

Expert emphasises healthy lifestyle in prostate cancer care.

Read more